Miguel completed his PhD in the laboratory of Maria A. Blasco at CNIO (Madrid, Spain) studying telomere and stem cell biology in the context of cancer and aging. He obtained an EMBO/Marie-Curie fellowship at the University of Edinburgh to investigate the enhancer-mediated regulation of cell identity and did his postdoctoral work on modelling complex cancer genotypes with CRISPR and base editing and exploring novel cancer therapies in the lab of Lukas E. Dow at the Weill Cornell School of Medicine (New York, USA). In 2018 he also contributed to the establishment of the Spanish Parliamentary Office of science advisory body.
Miguel joined Nature Cancer in 2019 and is based in the New York office.
Email: miguel.foronda@nature.com
Twitter: @krknrm
